on November 27, 2006
Circulation. 2006
Published online before print November 27, 2006, doi: 10.1161/CIRCULATIONAHA.106.179568
Published online before print November 27, 2006, doi: 10.1161/CIRCULATIONAHA.106.179568
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on ,
Abstract--Although for most children the process of atherosclerosis is subclinical, dramatically accelerated atherosclerosis occurs in some pediatric disease states, with clinical coronary events occurring in childhood and very early adult life. As with most scientific statements about children and the future risk for cardiovascular disease, there are no randomized trials documenting the effects of risk reduction on hard clinical outcomes. A growing body of literature, however, identifies the importance of premature cardiovascular disease in the course of certain pediatric diagnoses and addresses the response to risk factor reduction. For this scientific statement, a panel of experts reviewed what is known about very premature cardiovascular disease in 8 high-risk pediatric diagnoses and, from the science base, developed practical recommendations for management of cardiovascular risk.
Accepted on ,
Cardiovascular Risk Reduction in High-Risk Pediatric Patients. A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Endorsed by the American Academy of Pediatrics
Rae-Ellen W. Kavey MD, MPH, FAHA, Chair,
Key words: AHA Scientific Statements • atherosclerosis • cardiovascular diseases • risk factors • prevention • pediatrics
This article has been cited by other articles:
 |
|
 |
|
  S. A. Bakkaloglu, A. Saygili, L. Sever, A. Noyan, S. Akman, M. Ekim, N. Aksu, B. Doganay, N. Yildiz, A. Duzova, et al. Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3525 - 3532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Urbina, R. V. Williams, B. S. Alpert, R. T. Collins, S. R. Daniels, L. Hayman, M. Jacobson, L. Mahoney, M. Mietus-Snyder, A. Rocchini, et al. Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents: Recommendations for Standard Assessment for Clinical Research: A Scientific Statement From the American Heart Association Hypertension, November 1, 2009; 54(5): 919 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Schulte, A. Yilmaz, K. Shimada, M. C. Fishbein, E. L. Lowe, S. Chen, M. Wong, T. M. Doherty, T. Lehman, T. R. Crother, et al. Involvement of Innate and Adaptive Immunity in a Murine Model of Coronary Arteritis Mimicking Kawasaki Disease J. Immunol., October 15, 2009; 183(8): 5311 - 5318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. McCrindle Kawasaki Disease: A Childhood Disease With Important Consequences Into Adulthood Circulation, July 7, 2009; 120(1): 6 - 8. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zeitler Update on Nonautoimmune Diabetes in Children J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2215 - 2220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Robinson Nutrition Evidence-Based Guidelines for Treating Hyperlipidemia in Children With Type 1 Diabetes: A Case Presentation The Diabetes Educator, May 1, 2009; 35(3): 408 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Steinberger, S. R. Daniels, R. H. Eckel, L. Hayman, R. H. Lustig, B. McCrindle, and M. L. Mietus-Snyder Progress and Challenges in Metabolic Syndrome in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism Circulation, February 3, 2009; 119(4): 628 - 647. [Full Text] [PDF]
|
|
|
|
 |
|
 American Diabetes Association Standards of Medical Care in Diabetes--2009 Diabetes Care, January 1, 2009; 32(Supplement_1): S13 - S61. [Full Text] [PDF]
|
|
|
|
|
|
H. Senzaki Long-Term Outcome of Kawasaki Disease Circulation, December 16, 2008; 118(25): 2763 - 2772. [Full Text] [PDF]
|
|
|
|
|
|
P. O. Kwiterovich Jr. Recognition and Management of Dyslipidemia in Children and Adolescents J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4200 - 4209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. van der Graaf, C. Cuffie-Jackson, M. N. Vissers, M. D. Trip, C. Gagne, G. Shi, E. Veltri, H. J. Avis, and J. J.P. Kastelein Efficacy and Safety of Coadministration of Ezetimibe and Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia J. Am. Coll. Cardiol., October 21, 2008; 52(17): 1421 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Kumanyika, E. Obarzanek, N. Stettler, R. Bell, A. E. Field, S. P. Fortmann, B. A. Franklin, M. W. Gillman, C. E. Lewis, W. C. Poston II, et al. Population-Based Prevention of Obesity: The Need for Comprehensive Promotion of Healthful Eating, Physical Activity, and Energy Balance: A Scientific Statement From American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (Formerly the Expert Panel on Population and Prevention Science) Circulation, July 22, 2008; 118(4): 428 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. O. Kwiterovich Cut Points for Lipids and Lipoproteins in Children and Adolescents: Should They Be Reassessed? Clin. Chem., July 1, 2008; 54(7): 1113 - 1115. [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Daniels, F. R. Greer, and and the Committee on Nutrition Lipid Screening and Cardiovascular Health in Childhood Pediatrics, July 1, 2008; 122(1): 198 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Steinberger and A. S. Kelly Challenges of Existing Pediatric Dyslipidemia Guidelines: Call for Reappraisal Circulation, January 1, 2008; 117(1): 9 - 10. [Full Text] [PDF]
|
|
|
|
|
|
American Diabetes Association Standards of Medical Care in Diabetes--2008 Diabetes Care, January 1, 2008; 31(Supplement_1): S12 - S54. [Full Text] [PDF]
|
|
|
|
 |
|
 T. B. Vaughan, F. Ovalle, and E. Moreland Vascular disease in paediatric type 2 diabetes: the state of the art Diabetes and Vascular Disease Research, December 1, 2007; 4(4): 297 - 304. [Abstract] [PDF]
|
|
|
|
|
|
J. Mcgavock, E. Sellers, and H. Dean Physical activity for the prevention and management of youth-onset type 2 diabetes mellitus: focus on cardiovascular complications Diabetes and Vascular Disease Research, December 1, 2007; 4(4): 305 - 310. [Abstract] [PDF]
|
|
|
|
|
|
R. R. Rodriguez, R. A. Gomez-Diaz, J. T. Haj, F. J. A. Garnica, E. R. Soriano, E. N. Meguro, C. A. Aguilar-Salinas, and N. H. Wacher Carotid Intima-Media Thickness in Pediatric Type 1 Diabetic Patients Diabetes Care, October 1, 2007; 30(10): 2599 - 2602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ardoin, C. Sandborg, and L. Schanberg Review: Management of dyslipidemia in children and adolescents with systemic lupus erythematosus Lupus, August 1, 2007; 16(8): 618 - 626. [Abstract] [PDF]
|
|
|
|
|
|
B. Ranchin and S. Fargue Review: New treatment strategies for proliferative lupus nephritis: keep children in mind! Lupus, August 1, 2007; 16(8): 684 - 691. [Abstract] [PDF]
|
|
|
|
 |
|
 H.J. Avis, M.N. Vissers, E.A. Stein, F.A. Wijburg, M.D. Trip, J.J.P. Kastelein, and B.A. Hutten A Systematic Review and Meta-Analysis of Statin Therapy in Children With Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1803 - 1810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kelishadi Childhood Overweight, Obesity, and the Metabolic Syndrome in Developing Countries Epidemiol. Rev., May 3, 2007; (2007) mxm003v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. W. McCrindle and for the Writing Group Summary of the American Heart Association's Scientific Statement on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 982 - 985. [Full Text] [PDF]
|
|
|
|
 |
|
 R.-E. W. Kavey Academy endorses cardiovascular risk reduction statement AAP News, March 1, 2007; 28(3): 19 - 20. [Full Text] [PDF]
|
|
|
|
 |
|
 J. G.F. Cleland, A. P. Coletta, A. T. Abdellah, M. Nasir, N. Hobson, N. Freemantle, and A. L. Clark Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty Eur J Heart Fail, January 1, 2007; 9(1): 92 - 97. [Abstract] [Full Text] [PDF]
|
|